Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Honghua Xiaoyao tablets for premenstrual syndrome (liver depression and qi stagnation)
ChiCTR2300079127Phase 4Not yet recruiting
- Sponsor
- Guang'anmen Hospital
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Honghua Xiaoyao Pill in premenstrual syndrome (PMS) (2 arms), sponsored by Guang'anmen Hospital. Primary endpoint: DRSP premenstrual total score. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
Honghua Xiaoyao Pill
03
Conditions
premenstrual syndrome (PMS)
Beyond the preview
Go deeper on ChiCTR2300079127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300079127.